Restricted accessResearch articleFirst published online 2023-07
Safety and Feasibility of Laparoscopic Right or Extended Right Hemi Hepatectomy Following Modulation of the Future Liver Remnant in Patients with Colorectal Liver Metastases: A Systematic Review
Major hepatectomies after future liver remnant (FLR) modulation are technically demanding procedures, especially when performed as minimally invasive surgery. The aim of this systematic review is to assess current evidence regarding the safety and feasibility of laparoscopic right or extended right hemihepatectomies after FLR modulation.
Materials and Methods:
The Medline, PubMed, Cochrane Library, and Embase databases were searched for studies involving laparoscopic right or extended right hemihepatectomies after FLR modulation, from their inception to December 2021. Two reviewers independently selected eligible articles and assessed their quality using the Newcastle–Ottawa Quality Assessment Scale (NOS). Baseline characteristics and outcomes were extracted from the included studies and summarized.
Results:
Six studies were included. In these studies, the median length of stay after the second stage ranged from 4.5 to 15.5 days and postoperative complication rates between 4.5% and 42.8%. Overall, 7.4% of patients developed liver failure, and 90-day mortality occurred in 3.2% of patients. The R0 resection rate was 93.5%. Only one study reported long-term outcomes, describing comparable 3-year overall survival rates following laparoscopic and open surgery (80% versus 54%, P = .154).
Conclusions:
The current evidence is scarce, but it suggests that in experienced centers, laparoscopic right or extended right hemihepatectomy, following FLR modulation, is a safe and feasible procedure.
Get full access to this article
View all access options for this article.
References
1.
NordlingerB, SorbyeH, GlimeliusB, et al.Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): Long-term results of a randomised, controlled, phase 3 trial. Lancet Oncol, 2013; 14(12):1208–1215; doi: 10.1016/S1470-2045(13)70447-9
2.
BartschF, PascholdM, BaumgartJ, et al.Surgical resection for recurrent intrahepatic cholangiocarcinoma. World J Surg, 2019; 43(4):1105–1116; doi: 10.1007/s00268-018-04876-x
3.
de JongMC, MayoSC, PulitanoC, et al.Repeat curative intent liver surgery is safe and effective for recurrent colorectal liver metastasis: Results from an international multi-institutional analysis. J Gastrointest Surg, 2009; 13(12):2141–2151; doi: 10.1007/s11605-009-1050-0
4.
DixonM, CruzJ, SarwaniN, et al.The future liver remnant: Definition, evaluation, and management. Am Surg, 2021; 87(2):276–286; doi: 10.1177/0003134820951451
5.
RousP, LarimoreLD. Relation of the portal blood to liver maintenance: a demonstration of liver atrophy conditional on compensation. J Exp Med, 1920; 31(5):609–632; doi: 10.1084/jem.31.5.609
6.
KinoshitaH, SakaiK, HirohashiK, et al.Preoperative portal vein embolization for hepatocellular carcinoma. World J Surg, 1986; 10(5):803–808; doi: 10.1007/BF01655244
7.
MakuuchiM, ThaiBL, TakayasuK, et al.Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: A preliminary report. Surgery, 1990; 107(5):521–527.
8.
SchnitzbauerAA, LangSA, GoessmannH, et al.Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small-for-size settings. Ann Surg, 2012; 255(3):405–414; doi: 10.1097/SLA.0b013e31824856f5
9.
HeilJ, KorenblikR, HeidF, et al.Preoperative portal vein or portal and hepatic vein embolization: DRAGON collaborative group analysis. Br J Surg, 2021; 108(7):834–842; doi: 10.1093/bjs/znaa149
10.
van LiendenKP, van den EsschertJW, de GraafW, et al.Portal vein embolization before liver resection: a systematic review. Cardiovasc Intervent Radiol, 2013; 36(1):25–34; doi: 10.1007/s00270-012-0440-y
11.
Del BassoC, GaillardM, LainasP, et al.Current strategies to induce liver remnant hypertrophy before major liver resection. World J Hepatol, 2021; 13(11):1629–1641; doi: 10.4254/wjh.v13.i11.1629
12.
KonishiT, TakamotoT, HashimotoT, et al.Is portal vein embolization safe and effective for patients with impaired liver function?. J Surg Oncol, 2021; 123(8):1742–1749; doi: 10.1002/jso.26447
13.
GhosnM, KinghamTP, RidouaniF, et al.Percutaneous liver venous deprivation: outcomes in heavily pretreated metastatic colorectal cancer patients. HPB (Oxford), 2022; 24(3):404–412; doi: 10.1016/j.hpb.2021.08.816
14.
BeppuT, YamamuraK, OkabeH, et al.Oncological benefits of portal vein embolization for patients with hepatocellular carcinoma. Ann Gastroenterol Surg, 2020; 5(3):287–295; doi: 10.1002/ags3.12414
15.
KishiY, VautheyJN. Issues to be considered to address the future liver remnant prior to major hepatectomy. Surg Today, 202; 51(4):472–484; doi: 10.1007/s00595-020-02088-2
16.
Abu HilalM, AldrighettiL, DagherI, et al.The Southampton consensus guidelines for laparoscopic liver surgery: From indication to implementation. Ann Surg, 2018; 268(1):11–18; doi: 10.1097/SLA.0000000000002524
17.
WangZY, ChenQL, SunLL, et al.Laparoscopic versus open major liver resection for hepatocellular carcinoma: Systematic review and meta-analysis of comparative cohort studies. BMC Cancer, 2019; 19(1):1047; doi: 10.1186/s12885-019-6240-x
18.
CiriaR, CherquiD, GellerDA, et al.Comparative short-term benefits of laparoscopic liver resection: 9000 cases and climbing. Ann Surg, 2016; 263(4):761–777; doi: 10.1097/SLA.0000000000001413
19.
DelvecchioA, InchingoloR, LaforgiaR, et al.Liver resection vs radiofrequency ablation in single hepatocellular carcinoma of posterosuperior segments in elderly patients. World J Gastrointest Surg, 2021; 13(12):1696–1707; doi: 10.4240/wjgs.v13.i12.1696
20.
HeidF, Toti JC B, alzarotti CangerR, et al.Is laparoscopic major hepatectomy feasible and safe in Swiss cantonal hospitals?. Swiss Medical Weekly, 2021; 151:w30044; doi: 10.4414/smw.2021.w30044
21.
GörgecB, FichtingerRS, RattiF, et al.Comparing practice and outcome of laparoscopic liver resection between high-volume expert centres and nationwide low-to-medium volume centres. Br J Surg, 2021; 108(8):983–990; doi: 10.1093/bjs/znab096
22.
Robles-CamposR, Lopez-LopezV, BrusadinR, et al.Open versus minimally invasive liver surgery for colorectal liver metastases (LapOpHuva): A prospective randomized controlled trial. Surg Endosc, 2019; 33(12):3926–3936; doi: 10.1007/s00464-019-06679-0
23.
AghayanDL, Fretland ÅA, KazaryanAM, et al.Laparoscopic versus open liver resection in the posterosuperior segments: a sub-group analysis from the OSLO-COMET randomized controlled trial. HPB (Oxford), 2019; 21(11):1485–1490; doi: 10.1016/j.hpb.2019.03.358
24.
Abu HilalM, Di FabioF, SyedS, et al.Assessment of the financial implications for laparoscopic liver surgery: a single-centre UK cost analysis for minor and major hepatectomy. Surg Endosc, 2013; 27(7):2542–2550; doi: 10.1007/s00464-012-2779-1
25.
Fretland ÅA, DagenborgVJ, BjørnelvGMW, et al.Laparoscopic versus open resection for colorectal liver metastases: The OSLO-COMET randomized controlled trial. Ann Surg, 2018; 267(2):199–207; doi: 10.1097/SLA.0000000000002353
26.
GörgecB, CacciaguerraAB, AldrighettiLA, et al; International Study Group of Bile Leakage after LiverSurgery. Incidence and clinical impact of bile leakage after laparoscopic and open liver resection: An International Multicenter Propensity Score-Matched Study of 13,379 patients. J Am Coll Surg, 2022; 234(2):99–112; doi: 10.1097/XCS.0000000000000039
27.
van der HeijdeN, RattiF, AldrighettiL, et al.Laparoscopic versus open right posterior sectionectomy: An international, multicenter, propensity score-matched evaluation. Surg Endosc, 2021; 35(11):6139–6149; doi: 10.1007/s00464-020-08109-y
28.
PageMJ, McKenzieJE, BossuytPM, et al.The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. J Clin Epidemiol, 2021; 134:178–189; doi: 10.1016/j.jclinepi.2021.03.001
29.
BednarschJ, CziganyZ, SharmeenS, et al.ALPPS versus two-stage hepatectomy for colorectal liver metastases—A comparative retrospective cohort study. World J Surg Oncol. 2020; 18(1):140; doi: 10.1186/s12957-020-01919-3
30.
SchaddeE, ArdilesV, Robles-CamposR, et al.Early survival and safety of ALPPS: First report of the International ALPPS Registry. Ann Surg, 2014; 260(5):829–836; discussion 836–838; doi: 10.1097/SLA.0000000000000947
31.
StrasbergSM. Nomenclature of hepatic anatomy and resections: A review of the Brisbane 2000 system. J Hepatobiliary Pancreat Surg, 2005; 12(5):351–355; doi: 10.1007/s00534-005-0999-7
32.
WellsGA, SheaB, O'ConnellD, et al. The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-analyses; 2021. Available from: http://www.ohri.ca/Programs/clinical_epidemiology/oxford.asp. [Last accessed: March15, 2022].
33.
StangA. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol, 2010; 25(9):603–605; doi: 10.1007/s10654-010-9491-z
34.
Di FabioF, WhistanceR, RahmanS, et al.Exploring the role of laparoscopic surgery in two-stage hepatectomy for bilobar colorectal liver metastases. J Laparoendosc Adv Surg Tech A, 2012; 22(7):647–650; doi: 10.1089/lap.2012.0163
35.
GörgecB, SuhoolA, Al-JarrahR, et al.Surgical technique and clinical results of one- or two-stage laparoscopic right hemihepatectomy after portal vein embolization in patients with initially unresectable colorectal liver metastases: A case series. Int J Surg, 2020; 77:69–75; doi: 10.1016/j.ijsu.2020.03.005
36.
KilburnDJ, ChiowAK, LewinJ, et al.Laparoscopic approach to a planned two-stage hepatectomy for bilobar colorectal liver metastases. ANZ J Surg, 2016; 86(10):811–815; doi: 10.1111/ans.12748
37.
OkumuraS, GoumardC, GayetB, et al.Laparoscopic versus open two-stage hepatectomy for bilobar colorectal liver metastases: A bi-institutional, propensity score-matched study. Surgery, 2019; 166(6):959–966; doi: 10.1016/j.surg.2019.06.019
38.
FuksD, NomiT, OgisoS, et al.Laparoscopic two-stage hepatectomy for bilobar colorectal liver metastases. Br J Surg, 2015; 102(13):1684–1690; doi: 10.1002/bjs.9945
39.
TaillieuE, De MeyereC, D'HondtM. The role of the laparoscopic approach in two-stage hepatectomy for colorectal liver metastases: A single-center experience. Surg Endosc, 2022; 36(1):559–568; doi: 10.1007/s00464-021-08317-0
40.
AdamR, ImaiK, Castro BenitezC, et al.Outcome after associating liver partition and portal vein ligation for staged hepatectomy and conventional two-stage hepatectomy for colorectal liver metastases. Br J Surg, 2016; 103(11):1521–1529; doi: 10.1002/bjs.10256
41.
SparrelidE, OlthofPB, DasariBVM, et al.Current evidence on posthepatectomy liver failure: Comprehensive review. BJS Open, 2022; 6(6):zrac142; doi: 10.1093/bjsopen/zrac142
42.
MorE, Al-KurdA, YaacovAB, et al.Surgical outcomes of two-stage hepatectomy for colorectal liver metastasis: Comparison to a benchmark procedure. Hepatobiliary Surg Nutr, 2019; 8(1):29–36; doi: 10.21037/hbsn.2018.12.02
43.
TurriniO, EwaldJ, ViretF, et al.Two-stage hepatectomy: who will not jump over the second hurdle?. Eur J Surg Oncol, 2012; 38(3):266–273; doi: 10.1016/j.ejso.2011.12.009
44.
WichertsDA, MillerR, de HaasRJ, et al.Long-term results of two-stage hepatectomy for irresectable colorectal cancer liver metastases. Ann Surg, 2008; 248(6):994–1005; doi: 10.1097/SLA.0b013e3181907fd9
45.
BrouquetA, AbdallaEK, KopetzS, et al.High survival rate after two-stage resection of advanced colorectal liver metastases: Response-based selection and complete resection define outcome. J Clin Oncol, 2011; 29(8):1083–1090; doi: 10.1200/JCO.2010.32.6132
46.
NaritaM, OussoultzoglouE, JaeckD, et al.Two-stage hepatectomy for multiple bilobar colorectal liver metastases. Br J Surg, 2011; 98(10):1463–1475; doi: 10.1002/bjs.7580
47.
RegimbeauJM, CosseC, KaiserG, et al.Feasibility, safety and efficacy of two-stage hepatectomy for bilobar liver metastases of colorectal cancer: A LiverMetSurvey analysis. HPB (Oxford), 2017; 19(5):396–405; doi: 10.1016/j.hpb.2017.01.008
48.
PamechaV, Nedjat-ShokouhiB, GurusamyK, et al.Prospective evaluation of two-stage hepatectomy combined with selective portal vein embolisation and systemic chemotherapy for patients with unresectable bilobar colorectal liver metastases. Dig Surg, 2008; 25(5):387–393; doi: 10.1159/000176063
49.
ChavezMI, GholamiS, KimBJ, et al.Two-stage hepatectomy for bilateral colorectal liver metastases: A multi-institutional analysis. Ann Surg Oncol, 2021; 28(3):1457–1465; doi: 10.1245/s10434-020-09459-6
50.
LofS, VissersFL, KlompmakerS, et al.Risk of conversion to open surgery during robotic and laparoscopic pancreatoduodenectomy and effect on outcomes: International propensity score-matched comparison study. Br J Surg, 2021; 108(1):80–87; doi: 10.1093/bjs/znaa026
51.
2017 and 2015 European Society of Coloproctology (ESCP) collaborating groups. The impact of conversion on the risk of major complication following laparoscopic colonic surgery: An international, multicentre prospective audit. Colorectal Dis, 2018; 20(6):69–89; doi: 10.1111/codi.14371
52.
BlikkendaalMD, TwijnstraAR, StiggelboutAM, et al.Achieving consensus on the definition of conversion to laparotomy: A Delphi study among general surgeons, gynecologists, and urologists. Surg Endosc, 2013; 27(12):4631–4639; doi: 10.1007/s00464-013-3086-1
53.
YangC, WexnerSD, SafarB, et al.Conversion in laparoscopic surgery: does intraoperative complication influence outcome?. Surg Endosc, 2009; 23(11):2454–2458; doi: 10.1007/s00464-009-0414-6
54.
de Neree Tot BabberichMPM, van GroningenJT, DekkerE, et al.Laparoscopic conversion in colorectal cancer surgery; is there any improvement over time at a population level?. Surg Endosc, 2018; 32(7):3234–3246; doi: 10.1007/s00464-018-6042-2
55.
HallsMC, CiprianiF, BerardiG, et al.Conversion for unfavorable intraoperative events results in significantly worse outcomes during laparoscopic liver resection: Lessons learned from a multicenter review of 2861 cases. Ann Surg, 2018; 268(6):1051–1057; doi: 10.1097/SLA.0000000000002332
56.
LofS, KorrelM, van HilstJ, et al.Outcomes of elective and emergency conversion in minimally invasive distal pancreatectomy for pancreatic ductal adenocarcinoma: An International Multicenter Propensity Score-matched Study. Ann Surg, 2021; 274(6):e1001–e1007; doi: 10.1097/SLA.0000000000003717
57.
TranchartH, GaillardM, ChiricaM, et al.Multivariate analysis of risk factors for postoperative complications after laparoscopic liver resection. Surg Endosc, 2015; 29(9):2538–2544; doi: 10.1007/s00464-014-3965-0
58.
BennettS, BakerLK, MartelG, et al.The impact of perioperative red blood cell transfusions in patients undergoing liver resection: A systematic review. HPB (Oxford), 2017; 19(4):321–330; doi: 10.1016/j.hpb.2016.12.008
59.
CiprianiF, FiorentiniG, MagistriP, et al.Pure laparoscopic versus robotic liver resections: Multicentric propensity score-based analysis with stratification according to difficulty scores. J Hepatobiliary Pancreat Sci, 2021; doi: 10.1002/jhbp.1022
60.
HeinrichS, SeehoferD, CorvinusF, et al.Vorteile und Entwicklungspotenziale der laparoskopischen Leberchirurgie [Advantages and future perspectives of laparoscopic liver surgery]. Chirurg, 2021; 92(6):542–549; doi: 10.1007/s00104-020-01288-3
61.
AndreouA, AloiaTA, BrouquetA, et al.Margin status remains an important determinant of survival after surgical resection of colorectal liver metastases in the era of modern chemotherapy. Ann Surg, 2013; 257(6):1079–1088; doi: 10.1097/SLA.0b013e318283a4d1
62.
Benedetti CacciaguerraA, GörgecB, CiprianiF, et al.Risk factors of positive resection margin in laparoscopic and open liver surgery for colorectal liver metastases: A new perspective in the perioperative assessment: A European Multicenter Study. Ann Surg, 2022; 275(1):e213–e221; doi: 10.1097/SLA.0000000000004077
63.
Van DamRM, FichtingerR, AldrighettiL, et al.Laparoscopic versus open hemihepatectomy: The ORANGE II PLUS multicenter randomized controlled trial. Eur J Surg Oncol, 2022; 48(2):E40; doi: 10.1016/j.ejso.2021.12
64.
MachadoMA, MakdissiFF, SurjanRC, et al.Transition from open to laparoscopic ALPPS for patients with very small FLR: The initial experience. HPB (Oxford), 2017; 19(1):59–66; doi: 10.1016/j.hpb.2016.10.004
65.
MelandroF, GiovanardiF, HassanR, et al.Minimally invasive approach in the setting of ALPPS procedure: A systematic review of the literature. J Gastrointest Surg, 2019; 23(9):1917–1924; doi:10.1007/s11605-018-04092-x
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
